NO20075152L - Mellomprodukter for fremstilling av trans-5-klor-2-metyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oksepino[4,5-C]pyrrol - Google Patents

Mellomprodukter for fremstilling av trans-5-klor-2-metyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oksepino[4,5-C]pyrrol

Info

Publication number
NO20075152L
NO20075152L NO20075152A NO20075152A NO20075152L NO 20075152 L NO20075152 L NO 20075152L NO 20075152 A NO20075152 A NO 20075152A NO 20075152 A NO20075152 A NO 20075152A NO 20075152 L NO20075152 L NO 20075152L
Authority
NO
Norway
Prior art keywords
preparation
oxepino
dibenz
pyrrole
tetrahydro
Prior art date
Application number
NO20075152A
Other languages
English (en)
Norwegian (no)
Inventor
Gerardus Johannes Kemperman
Jacobus Johannes Marie Linden
Michael R Reeder
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of NO20075152L publication Critical patent/NO20075152L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/14—[b,f]-condensed

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20075152A 2005-04-07 2007-10-10 Mellomprodukter for fremstilling av trans-5-klor-2-metyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oksepino[4,5-C]pyrrol NO20075152L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05102742 2005-04-07
PCT/EP2006/061409 WO2006106136A1 (en) 2005-04-07 2006-04-06 Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole

Publications (1)

Publication Number Publication Date
NO20075152L true NO20075152L (no) 2007-11-01

Family

ID=35511130

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075152A NO20075152L (no) 2005-04-07 2007-10-10 Mellomprodukter for fremstilling av trans-5-klor-2-metyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oksepino[4,5-C]pyrrol

Country Status (28)

Country Link
EP (2) EP2154134B1 (ru)
JP (1) JP2008534657A (ru)
KR (1) KR20070116973A (ru)
CN (2) CN101175741B (ru)
AR (1) AR063188A1 (ru)
AT (1) ATE447564T1 (ru)
AU (1) AU2006231281B2 (ru)
BR (1) BRPI0610677A2 (ru)
CA (1) CA2603181A1 (ru)
CY (1) CY1109722T1 (ru)
DE (1) DE602006010132D1 (ru)
DK (1) DK1710241T3 (ru)
ES (1) ES2333980T3 (ru)
HK (1) HK1094800A1 (ru)
HR (1) HRP20100031T1 (ru)
IL (1) IL186354A0 (ru)
MX (1) MX2007012446A (ru)
NO (1) NO20075152L (ru)
NZ (1) NZ562125A (ru)
PL (1) PL1710241T3 (ru)
PT (1) PT1710241E (ru)
RS (1) RS51341B (ru)
RU (1) RU2397164C2 (ru)
SI (1) SI1710241T1 (ru)
TW (1) TW200716589A (ru)
UA (2) UA93043C2 (ru)
WO (1) WO2006106136A1 (ru)
ZA (2) ZA200708493B (ru)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5027477B2 (ja) * 2005-10-21 2012-09-19 住友化学株式会社 ジベンゾオキセピノピロール化合物およびその中間体の製造方法ならびに新規中間体
TW200817414A (en) * 2006-07-05 2008-04-16 Organon Nv Process for the preparation of asenapine and intermediate products used in said process
CN101563312A (zh) * 2006-12-22 2009-10-21 住友化学株式会社 阿塞那平合成中间体的制备方法
US7875729B2 (en) * 2007-01-05 2011-01-25 Synthon Bv Process for making asenapine
JP5245428B2 (ja) 2007-07-06 2013-07-24 住友化学株式会社 トランス−ジベンゾオキセノピロール化合物の製造方法およびその中間体
CA2710800A1 (en) * 2008-01-04 2009-07-16 N.V. Organon Process for the preparation of asenapine and intermediate products used in said process
TW201113018A (en) 2009-06-24 2011-04-16 Organon Nv Injectable formulations containing asenapine and method of treatment using same
CN101851242B (zh) * 2010-05-25 2013-07-24 上海皓元生物医药科技有限公司 阿塞那平中间体的制备方法
EP2598496B1 (en) 2010-07-29 2014-03-19 Laboratorios Lesvi, S.L. Novel process for the preparation of asenapine
WO2012038975A2 (en) * 2010-09-22 2012-03-29 Msn Laboratories Limited Process for the preparation of (3ars,12brs)-5-chloro-2-methyl-2,3,3a12b-tetrahydro-1hdibenzo[2,3:6,7] oxepino [4,5-c]pyrrole maleate and it's pharmaceutical composition thereof
EP2468751B1 (en) 2010-12-24 2016-03-16 Medichem, S.A. Processes for the preparation of 5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole
ITMI20110734A1 (it) * 2011-05-02 2012-11-03 Olon Spa Sali cristallini di asenapina
WO2013024492A2 (en) 2011-07-01 2013-02-21 Megafine Pharma (P) Ltd. A process for the preparation of asenapine and novel salts thereof
CN102952144A (zh) * 2011-08-29 2013-03-06 上海华拓医药科技发展股份有限公司 阿森纳平马来酸盐的晶型、制备方法及其药物组合物
WO2013080069A1 (en) * 2011-11-28 2013-06-06 Ranbaxy Laboratories Limited Process for the preparation of asenapine intermediate
CN102746209A (zh) * 2012-06-20 2012-10-24 盛世泰科生物医药技术(苏州)有限公司 一种3-（2-（4-氯苯氧基）苯基）-1-甲基-2,4-二酮的合成方法
CN103965206A (zh) * 2013-01-29 2014-08-06 北京京卫燕康药物研究所有限公司 一种阿色纳品马来酸盐的新晶型及制备方法
CN103113379A (zh) * 2013-03-12 2013-05-22 盛世泰科生物医药技术(苏州)有限公司 阿塞那平马来酸盐的合成工艺
CN103254202A (zh) * 2013-05-19 2013-08-21 甘肃皓天化学科技有限公司 阿塞纳平的制备方法
CN103342707B (zh) * 2013-06-28 2015-09-02 甘肃皓天化学科技有限公司 用于制备阿塞纳平中间体的制备方法
CN104447771A (zh) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 一种稳定的马来酸阿塞那平化合物
CN103864802B (zh) * 2014-03-31 2016-08-17 四川科伦药业股份有限公司 马来酸阿塞那平的制备方法
CN105693735A (zh) * 2016-01-15 2016-06-22 万特制药(海南)有限公司 马来酸阿塞那平一种制备方法
MX2019007391A (es) 2016-12-20 2019-08-16 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina.
EP3558276A1 (en) 2016-12-20 2019-10-30 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
WO2019002204A1 (en) 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND SILICONE-TYPE ACRYLIC HYBRID POLYMER
CN109200025A (zh) * 2017-06-29 2019-01-15 哈尔滨莱博通药业有限公司 一种阿森纳平马来酸盐舌下片
WO2019243452A1 (en) 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
CN110183457A (zh) * 2019-06-27 2019-08-30 浙江天顺药业有限公司 一种阿塞那平及其制备方法
CN112194665A (zh) * 2020-10-20 2021-01-08 连云港杰瑞药业有限公司 一种合成阿塞那平中间体的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605526A (nl) * 1976-05-24 1977-11-28 Akzo Nv Nieuwe tetracyclische derivaten.
HU225051B1 (en) 1994-03-02 2006-05-29 Organon Ireland Ltd Sublingual or buccal pharmaceutical compositions containing trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole
WO1999032108A1 (en) 1997-12-19 1999-07-01 Akzo Nobel N.V. Org-5222 in the treatment of depression

Also Published As

Publication number Publication date
CA2603181A1 (en) 2006-10-12
RU2007141161A (ru) 2009-05-20
ATE447564T1 (de) 2009-11-15
EP1710241A1 (en) 2006-10-11
ZA200708493B (en) 2009-09-30
CN101175741A (zh) 2008-05-07
DK1710241T3 (da) 2010-03-01
AR063188A1 (es) 2009-01-14
DE602006010132D1 (de) 2009-12-17
CN101175741B (zh) 2011-06-22
UA93044C2 (en) 2011-01-10
HK1094800A1 (en) 2007-04-13
SI1710241T1 (sl) 2010-02-26
CN1861604A (zh) 2006-11-15
TW200716589A (en) 2007-05-01
EP2154134A1 (en) 2010-02-17
CY1109722T1 (el) 2014-04-09
MX2007012446A (es) 2007-11-07
AU2006231281B2 (en) 2011-04-28
AU2006231281A1 (en) 2006-10-12
PT1710241E (pt) 2009-12-10
EP1710241B1 (en) 2009-11-04
CN1861604B (zh) 2011-08-31
KR20070116973A (ko) 2007-12-11
UA93043C2 (ru) 2011-01-10
ES2333980T3 (es) 2010-03-03
RU2397164C2 (ru) 2010-08-20
RS51341B (en) 2011-02-28
JP2008534657A (ja) 2008-08-28
BRPI0610677A2 (pt) 2012-10-30
IL186354A0 (en) 2008-01-20
HRP20100031T1 (hr) 2010-02-28
EP2154134B1 (en) 2012-10-24
NZ562125A (en) 2010-08-27
ZA200708490B (en) 2008-10-29
WO2006106136A1 (en) 2006-10-12
PL1710241T3 (pl) 2010-04-30

Similar Documents

Publication Publication Date Title
NO20075152L (no) Mellomprodukter for fremstilling av trans-5-klor-2-metyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oksepino[4,5-C]pyrrol
NO20075142L (no) krystallformer av asenapinmaleat
BRPI0514925A (pt) derivados de pirrol[2,3-c]piridina e processos para a preparação destes
NO20061363L (no) Pyrazolo- og imidazo- pyrimidinderivater
WO2005108358A3 (en) Pyrrolidine derivatives useful as bace inhibitors
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
NO20063486L (no) Bicykloesterderivater
MX2007006397A (es) Derivados de tetrahidropirano.
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
NO20071095L (no) Hittil ukjente tiofenderivater
WO2004056827A3 (en) Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
WO2006103277A3 (en) 2 , 4 , 5-substituted piperidines as renin inhibitors
NO20082511L (no) Nye pyridopyraziner og deres anvendelse som kinasemodulatorer
CA2492096A1 (en) Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides
TW200500339A (en) Pyrrolidine derivatives, and process for the preparation
NO20061157L (no) 4-pyramidonderivater og deres anvendelse som peptidylpeptidmeinbibitorer
IL162461A0 (en) Polymorphs of clopidogrel hydrogensulfate
ATE518858T1 (de) Pyrroloä3,2-cüpyridinderivate und herstellungsverfahren dafür
WO2005021536A3 (en) Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
WO2005105753A3 (en) Naphthalimide derivatives, methods for their production and pharmaceutical compositions therefrom
WO2008083950A3 (de) Spirocyclische tetronsäure-derivative
TW200626600A (en) Octahydropyrrolo[3, 4-c]pyrrole derivatives
NO20070550L (no) Fremgangsmate for fremstilling av pyrrolotriazinforbindelser
NO20071805L (no) Alkylidentetrahydronaftalenderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere.
DK1838683T3 (da) Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application